What You Should Know
Value-based oncology navigation and management leader Thyme Care announced a Series E financing round exceeding $125M, led by Morgan Health.Strategic and institutional syndication includes major national payers and healthcare venture firms: Humana, CVS Health Ventures, AlleyCorp, HealthQuest Capital, Foresite Capital, Concord Health Partners, Frist Cressey Ventures, Town Hall Ventures, and a16z Bio + Health.The company manages more than $7Bin annual oncology spend, with
Read More
Oncology Platform
N-Power Medicine Closes $32M to Expand Community Oncology Research
What You Should Know
Oncology drug development platform N-Power Medicine closed a $32M Series B financing round to scale its community oncology clinical research network and expand adoption of its Prospective External Control Arms (ProECA) technology.The financing features Labcorp Venture Fund as a new strategic investor, alongside continued participation from Merck Global Health Innovation Fund (Merck GHI), Innovatus Capital Partners, and a leading U.S.-based biotechnology investor.Solves a
Read More
Triomics Secures $22M to Automate Oncology AI Chart Abstraction
What You Should Know
Oncology AI innovator Triomics has announced a $22M Series B financing round led by Battery Ventures, pushing its total venture funding past $36 million.The expansion round features strategic backing from Lightspeed, Nexus Venture Partners, Y Combinator, Oncology Ventures, and Precision Health Informatics (a subsidiary of Texas Oncology).Triomics replaces manual medical chart curation by deploying domain-specific AI agents that ingest unstructured longitudinal records,
Read More
Greatly Health Secures $4M to Scale MSK-Validated Integrative Oncology Platform
What You Should Know
Greatly Health raised a $4 million seed round co-led by Pear VC and Commonweal Ventures to bring integrative oncology to a broader patient population.The company's virtual model was originally developed and validated at Memorial Sloan Kettering Cancer Center (MSK).In clinical trials, the program demonstrated a 16% absolute improvement in overall survival at two years and a 69% reduction in hospitalizations.The platform provides live, expert-led group sessions in exercise,
Read More
CareDx to Acquire Naveris for $160M to Expand into HPV-Driven Cancer MRD Monitoring
What You Should Know
CareDx has entered into a definitive agreement to acquire Naveris, a precision oncology company specializing in blood-based monitoring for viral-mediated cancers.The deal includes $160M in up-front cash, with potential for an additional $100M based on future revenue milestones.Naveris’ flagship platform utilizes Tumor Tissue Modified Viral (TTMV®) DNA to detect and monitor HPV-driven cancers with high accuracy.The acquisition is expected to close in the third quarter of
Read More
Sonire Therapeutics Raises $18M to Transform Pancreatic Cancer Treatment
What You Should Know
The Raise: Clinical-stage medical device company Sonire Therapeutics has announced an $18M Series A financing round. The round was led by Santé Ventures, with participation from Fast Track Initiative (FTI), Nomura SPARX Investment, and SBI Investment.The Technology: Sonire has developed a proprietary High-Intensity Focused Ultrasound (HIFU) therapy system for the non-invasive thermal ablation of solid tumors.The Clinical Target: The company is initially focusing on
Read More
Mayo Clinic Platform Standardizes Cancer Data to Speed Up Trials
Mayo Clinic Platform Standardizes Cancer Data to Speed Up Trials
What You Should Know
The Upgrade: Mayo Clinic Platform_Orchestrate has launched new capabilities that allow researchers to access standardized, "research-ready" cancer data.The Standard: The platform now utilizes the OMOP Oncology framework, which structures complex, messy data (like pathology reports and tumor staging) into a consistent format that algorithms can easily analyze.The Future: Later this year, Mayo will
Read More
SimonMed Launches Ultrasound+ AI Program for Enhanced Breast and Thyroid Cancer Detection
What You Should Know:
- SimonMed Imaging, one of the largest outpatient medical imaging providers and radiology practices in the United States, today announced the launch of Ultrasound+, an AI-enabled ultrasound program.
- The program is powered by the FDA-cleared software, Koios DS, and is designed to assist with breast and thyroid cancer detection.
Embedding AI for Earlier and More Accurate Detection
Ultrasound+ represents a significant step in making advanced imaging
Read More
Daymark Health Secures $20M to Scale Value-Based Cancer Care
What You Should Know:
- Daymark Health, a company dedicated to redefining the cancer care experience secures $20M in Series A funding round led by Healthier Capital and Blue Venture Fund, with continued participation from existing investors including Yosemite, Maverick Ventures, and Oncology Ventures.
- The investment will allow Daymark Health to continue scaling its cancer care platform, forge new partnerships with health plans and providers, and bring its innovative technology to
Read More
MedStar Health Pilots On-Demand Cancer Care with Reimagine Care
What You Should Know:
- Reimagine Care, the nation’s leading provider of on-demand cancer care, today announced a pilot collaboration with MedStar Health, the largest healthcare provider in Maryland and the Washington, D.C., region.
- MedStar Health will integrate Reimagine Care’s innovative on-demand oncology care platform into its cancer care delivery model, offering patients a seamless extension from their in-clinic care plan into the home.
Extending High-Quality Cancer Care
Read More
